Angioplasty with paclitaxel coated balloon reduces restenosis in peripheral artery diseaseBMJ 2015; 350 doi: https://doi.org/10.1136/bmj.h3451 (Published 26 June 2015) Cite this as: BMJ 2015;350:h3451
- Susan Mayor
Percutaneous transluminal angioplasty using a paclitaxel coated balloon notably improves arterial patency at one year when compared with the same procedure using a standard uncoated balloon in patients with femoropopliteal artery disease, a study in the New England Journal of Medicine has shown.1
Treatment with percutaneous transluminal angioplasty is effective in restoring blood flow to patients with atherosclerotic disease in the femoral and popliteal arteries. But restenosis occurs in nearly two thirds of patients within a year of the procedure.
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial